Progyny, Inc. (NASDAQ:PGNY) Holdings Lifted by Intech Investment Management LLC

Intech Investment Management LLC boosted its holdings in Progyny, Inc. (NASDAQ:PGNY) by 282.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 42,013 shares of the company’s stock after acquiring an additional 31,014 shares during the quarter. Intech Investment Management LLC’s holdings in Progyny were worth $704,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Hsbc Holdings PLC grew its stake in shares of Progyny by 703.9% in the 2nd quarter. Hsbc Holdings PLC now owns 46,475 shares of the company’s stock worth $1,328,000 after purchasing an additional 40,694 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Progyny by 3.0% in the second quarter. Bank of New York Mellon Corp now owns 756,228 shares of the company’s stock valued at $21,636,000 after buying an additional 22,012 shares in the last quarter. Kestrel Investment Management Corp acquired a new stake in shares of Progyny during the 2nd quarter valued at $5,005,000. Farallon Capital Management LLC boosted its stake in shares of Progyny by 120.8% during the 2nd quarter. Farallon Capital Management LLC now owns 1,308,500 shares of the company’s stock worth $37,436,000 after acquiring an additional 715,900 shares in the last quarter. Finally, Kornitzer Capital Management Inc. KS grew its holdings in shares of Progyny by 15.7% in the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 976,501 shares of the company’s stock worth $16,366,000 after acquiring an additional 132,672 shares during the last quarter. 94.93% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on PGNY shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $25.00 target price on shares of Progyny in a report on Tuesday, October 1st. JPMorgan Chase & Co. decreased their target price on shares of Progyny from $31.00 to $22.00 and set an “overweight” rating for the company in a report on Thursday, September 19th. Bank of America cut their price target on shares of Progyny from $22.00 to $21.00 and set a “buy” rating on the stock in a report on Wednesday, November 13th. Barclays decreased their price objective on shares of Progyny from $30.00 to $17.00 and set an “overweight” rating for the company in a research note on Thursday, November 14th. Finally, BTIG Research downgraded shares of Progyny from a “buy” rating to a “neutral” rating in a research note on Wednesday, August 7th. Eight analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Progyny presently has an average rating of “Hold” and an average target price of $25.42.

Progyny Stock Up 0.6 %

Progyny stock opened at $15.57 on Friday. Progyny, Inc. has a 12 month low of $13.39 and a 12 month high of $42.08. The company’s fifty day simple moving average is $15.84 and its 200-day simple moving average is $22.31. The stock has a market cap of $1.33 billion, a P/E ratio of 26.85, a P/E/G ratio of 1.79 and a beta of 1.44.

Progyny (NASDAQ:PGNY) last issued its earnings results on Tuesday, November 12th. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). Progyny had a net margin of 5.03% and a return on equity of 11.36%. The firm had revenue of $286.63 million during the quarter, compared to analysts’ expectations of $296.85 million. During the same quarter last year, the firm earned $0.16 EPS. The business’s revenue for the quarter was up 2.0% compared to the same quarter last year. On average, equities research analysts expect that Progyny, Inc. will post 0.58 earnings per share for the current fiscal year.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.